The company took the lead in passing the national drug GMP certification, the international environmental management ISO 1400 1 certification, and the international occupational health and safety responsibility OHSMS 1800 1 certification, and was listed as the "National Pharmaceutical Quality Integrity Demonstration Enterprise". At present, two products have passed FDA certification and two products have passed EU certification.
Oak. , Lansu. And walker. 3 are famous brand products in Jiangsu Province; It is a national 863 high-tech project, and only three companies are allowed to produce drugs in the world (the United States, the European Union and China-Changzhou);
New drugs were first approved in China, and a series of high-tech new drugs were successfully introduced to the market for the benefit of patients. Won the national quality silver award and provincial quality gold award for many times. Aoke Ogilvy & Mather product series has been selected as famous brand products in Jiangsu Province for four consecutive years.
The company has a raw material factory and a preparation factory, with agile lean manufacturing and flexible production capacity. Specializing in the production of chemically active intermediates and preparations. Annual output of 25 kinds of raw material intermediates 100 tons, of which 50 tons are exported by self; 2 million freeze-dried powder injections and 50 million water injections; 2 billion capsules, tablets and controlled-release sustained-release preparations; 654.38+million creams and new transdermal patches. Freeze-dried powder injection, water injection workshop, solid preparation workshop, patch workshop and raw material pharmaceutical factory all passed the national GMP certification.
Changzhou No.4 Pharmaceutical Co., Ltd. is committed to the research, development, production and marketing of new drugs such as cardiovascular drugs, respiratory drugs, psychoactive drugs and antiallergic drugs, and continues to innovate in technology, cultivate the intellectual property system of independent invention patents, enhance core competitiveness, and build its own brand, which will challenge new fields such as chiral drugs, polypeptide biochemical drugs, anti-tumor drugs and plant drugs … and make unremitting efforts for the cause of human health!
Legal Representative: Tu Yongrui
Date of establishment: 1996-03-25
Registered capital: US$ 7.08 million.
Location: Jiangsu Province
Unified social credit code: 91320400608126461p.
Operating conditions: In operation.
Industry: manufacturing industry
Company type: limited liability company (Sino-foreign joint venture)
English name: Changsha Siyao Pharmaceutical Co., Ltd.
Staff size: 500-999 people.
Enterprise address: Meilongba, the southern suburb of Changzhou, Jiangsu Province
Scope: Licensed business items: pharmaceutical production (subject to the production scope approved by the pharmaceutical production license). (Projects subject to approval according to law can only be operated after approval by relevant departments)